8-K

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): September 25, 2007

Merck & Co., Inc.
__________________________________________
(Exact name of registrant as specified in its charter)

New Jersey	1-3305	22-1109110
_____________________ (State or other jurisdiction	_____________ (Commission	______________ (I.R.S. Employer
of incorporation)	File Number)	Identification No.)
One Merck Drive, P.O. Box 100, Whitehouse Station, New Jersey		08889
_________________________________ (Address of principal executive offices)		___________ (Zip Code)

Registrant’s telephone number, including area code: 908-423-1000

Not Applicable
______________________________________________
Former name or former address, if changed since last report

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(d) Incorporated by reference is a press release issued by Merck & Co., Inc. (the "Company") on September 19, 2007, attached as Exhibit 99.1, announcing the election of Steven F. Goldstone to the Company's Board of Directors, effective September 25, 2007. Board Committee assignments for Mr. Goldstone will be determined at a later date.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit 99.1 Press Release issued September 19, 2007

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Merck & Co., Inc.
September 25, 2007	By:	/s/ Debra A. Bollwage
		Name: Debra A. Bollwage
		Title: Senior Assistant Secretary

Exhibit Index

Exhibit No.	Description
99.1	Press release issued September 19, 2007

EX-99.1

Exhibit 99.1

MERCK LOGO

News Release

Media Contacts: Amy Rose
(908) 423-6537 Investor Contact: Graeme Bell
(908) 423-5185

Steven F. Goldstone Elected to Merck Board of Directors

WHITEHOUSE STATION, N.J., Sept. 19, 2007 – Merck & Co., Inc. today announced that Steven F. Goldstone, 61, founder of Silver Spring Group, a private investment firm, will join the Company’s Board of Directors effective Sept. 25. With his election, Mr. Goldstone will become one of 10 outside directors on the 11-member board. Mr. Goldstone will stand for election by the Company’s stockholders in April 2008.

Mr. Goldstone was chairman and chief executive officer of RJR Nabisco, Inc., one of the world’s largest consumer products companies, from 1995 until his retirement five years later in 2000. Prior to that role, he was a partner at the New York law firm of Davis Polk & Wardwell from 1978 to 1995.

He is currently the non-executive chairman of the Board of Directors of ConAgra Foods, Inc. He also serves on the boards of two other New York Stock Exchange-listed companies, Greenhill & Co. and American Standard Companies, Inc. Mr. Goldstone is chairman of the Founders Hall Foundation, Inc. and a trustee of the Aldrich Museum of Contemporary Art. He recently served as chairman of the Roundabout Theatre Company of New York and as an overseer at the University of Pennsylvania.

A graduate of the University of Pennsylvania, Mr. Goldstone earned his law degree from New York University in 1970.

About Merck

Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891, Merck currently discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. The Company devotes extensive efforts to increase access to medicines through far-reaching programs that not only donate Merck medicines but help deliver them to the people who need them. Merck also publishes unbiased health information as a not-for-profit service. For more information, visit www.merck.com.

# # #